CRISPR-edited tumor-infiltrating lymphocytes are emerging as a promising alternative to CAR T-cell therapy for solid cancers.

An epigenetic mechanism by which tumors manage to hide from the body's immune defenses has just been described by an ...

First-in-human healthy volunteers trial showed SYX-5219 was safe and well toleratedSystemic immunomodulation of type 2 inflammation demonstrated ...

High-level results from a planned interim analysis of the VOLGA Phase III trial showed perioperative treatment with Imfinzi (durvalumab) in ...

The appendix is an organ we tend not to think about until it acts up, causes illness and needs to be removed surgically.

Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd., today announced that the U.S. Food and Drug Administration (FDA) has approved INQOVI (decitabine and cedazuridine) plus venetoclax as a ...

China: Levofloxacin demonstrated good clinical effectiveness in children with refractory Mycoplasma pneumoniae pneumonia ...

Objective B-cell activating factor (BAFF) is essential for B-cell survival and innate immune activation, and its ...